↓ Skip to main content
What is this page? Embed badge

Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)

Overview of attention for article published in BMC Cancer, July 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
85 Dimensions

Readers on

mendeley
95 Mendeley
Summary X Dimensions citations
So far, Dimensions has found 85 publications that cite this research output.

85

The most recent citing publications are shown below. View all 85 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.